A citation-based method for searching scientific literature


List of co-cited articles
94 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
K Shailubhai, H H Yu, K Karunanandaa, J Y Wang, S L Eber, Y Wang, N S Joo, H D Kim, B W Miedema, S Z Abbas,[...]. Cancer Res 2000
170
35

Familial diarrhea syndrome caused by an activating GUCY2C mutation.
Torunn Fiskerstrand, Najla Arshad, Bjørn Ivar Haukanes, Rune Rose Tronstad, Khanh Do-Cong Pham, Stefan Johansson, Bjarte Håvik, Siv L Tønder, Shawn E Levy, Damien Brackman,[...]. N Engl J Med 2012
120
35

Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier.
Xiaonan Han, Elizabeth Mann, Shila Gilbert, Yanfang Guan, Kris A Steinbrecher, Marshall H Montrose, Mitchell B Cohen. PLoS One 2011
61
35

Murine guanylate cyclase C regulates colonic injury and inflammation.
Kris A Steinbrecher, Eleana Harmel-Laws, Monica P Garin-Laflam, Elizabeth A Mann, Lucas D Bezerra, Simon P Hogan, Mitchell B Cohen. J Immunol 2011
40
35

Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.
Kunwar Shailubhai, Stephen Comiskey, John A Foss, Rong Feng, Laura Barrow, Gail M Comer, Gary S Jacob. Dig Dis Sci 2013
64
35

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.
Robert W Busby, Alexander P Bryant, Wilmin P Bartolini, Etchell A Cordero, Gerhard Hannig, Marco M Kessler, Shalina Mahajan-Miklos, Christine M Pierce, Robert M Solinga, Li Jing Sun,[...]. Eur J Pharmacol 2010
142
29

Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C.
Hila Romi, Idan Cohen, Daniella Landau, Suliman Alkrinawi, Baruch Yerushalmi, Reli Hershkovitz, Nitza Newman-Heiman, Garry R Cutting, Rivka Ofir, Sara Sivan,[...]. Am J Hum Genet 2012
57
29

Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.
Kunwar Shailubhai, Vaseem Palejwala, Krishna Priya Arjunan, Sayali Saykhedkar, Bradley Nefsky, John A Foss, Stephen Comiskey, Gary S Jacob, Scott E Plevy. World J Gastrointest Pharmacol Ther 2015
39
29

Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
Inmaculada Silos-Santiago, Gerhard Hannig, Helene Eutamene, Elena E Ustinova, Sylvie G Bernier, Pei Ge, Christopher Graul, Sarah Jacobson, Hong Jin, Elaine Liong,[...]. Pain 2013
49
23

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.
Satish Rao, Anthony J Lembo, Steven J Shiff, Bernard J Lavins, Mark G Currie, Xinwei D Jia, Kelvin Shi, James E MacDougall, James Z Shao, Paul Eng,[...]. Am J Gastroenterol 2012
238
23

Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
Joel Castro, Andrea M Harrington, Patrick A Hughes, Christopher M Martin, Pei Ge, Courtney M Shea, Hong Jin, Sarah Jacobson, Gerhard Hannig, Elizabeth Mann,[...]. Gastroenterology 2013
162
23


Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
William D Chey, Anthony J Lembo, Bernard J Lavins, Steven J Shiff, Caroline B Kurtz, Mark G Currie, James E MacDougall, Xinwei D Jia, James Z Shao, Donald A Fitch,[...]. Am J Gastroenterol 2012
265
23

Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase.
F K Hamra, L R Forte, S L Eber, N V Pidhorodeckyj, W J Krause, R H Freeman, D T Chin, J A Tompkins, K F Fok, C E Smith. Proc Natl Acad Sci U S A 1993
296
23

Guanylate cyclase C deficiency causes severe inflammation in a murine model of spontaneous colitis.
Eleana Harmel-Laws, Elizabeth A Mann, Mitchell B Cohen, Kris A Steinbrecher. PLoS One 2013
24
23


Expression of guanylin is downregulated in mouse and human intestinal adenomas.
K A Steinbrecher, T M Tuohy, K Heppner Goss, M C Scott, D P Witte, J Groden, M B Cohen. Biochem Biophys Res Commun 2000
66
23


The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Jieru Egeria Lin, Peng Li, Adam Eugene Snook, Stephanie Schulz, Abhijit Dasgupta, Terry Marie Hyslop, Ahmara Vivian Gibbons, Glen Marszlowicz, Giovanni Mario Pitari, Scott Arthur Waldman. Gastroenterology 2010
80
23

Two randomized trials of linaclotide for chronic constipation.
Anthony J Lembo, Harvey A Schneier, Steven J Shiff, Caroline B Kurtz, James E MacDougall, Xinwei D Jia, James Z Shao, Bernard J Lavins, Mark G Currie, Donald A Fitch,[...]. N Engl J Med 2011
217
23

Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Peng Li, Stephanie Schulz, Alessandro Bombonati, Juan P Palazzo, Terry M Hyslop, Yihuan Xu, Amy A Baran, Linda D Siracusa, Giovanni M Pitari, Scott A Waldman. Gastroenterology 2007
101
23

GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity.
Jieru Egeria Lin, Adam Eugene Snook, Peng Li, Brian Arthur Stoecker, Gilbert Won Kim, Michael Sullivan Magee, Alex Vladimir Mejia Garcia, Michael Anthony Valentino, Terry Hyslop, Stephanie Schulz,[...]. PLoS One 2012
59
23

Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
Robert W Busby, Marco M Kessler, Wilmin P Bartolini, Alexander P Bryant, Gerhard Hannig, Carolyn S Higgins, Robert M Solinga, Jenny V Tobin, James D Wakefield, Caroline B Kurtz,[...]. J Pharmacol Exp Ther 2013
81
17

Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.
H Eutamene, S Bradesi, M Larauche, V Theodorou, C Beaufrand, G Ohning, J Fioramonti, M Cohen, A P Bryant, C Kurtz,[...]. Neurogastroenterol Motil 2010
131
17

Functional bowel disorders.
George F Longstreth, W Grant Thompson, William D Chey, Lesley A Houghton, Fermin Mearin, Robin C Spiller. Gastroenterology 2006
17


Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.
G M Pitari, M D Di Guglielmo, J Park, S Schulz, S A Waldman. Proc Natl Acad Sci U S A 2001
126
17

Characterization of human uroguanylin: a member of the guanylin peptide family.
T Kita, C E Smith, K F Fok, K L Duffin, W M Moore, P J Karabatsos, J F Kachur, F K Hamra, N V Pidhorodeckyj, L R Forte. Am J Physiol 1994
118
17


Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21.
Nirmalya Basu, Sayanti Saha, Imran Khan, Subbaraya G Ramachandra, Sandhya S Visweswariah. J Biol Chem 2014
31
17

Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.
F K Hamra, S L Eber, D T Chin, M G Currie, L R Forte. Proc Natl Acad Sci U S A 1997
95
17


Guanylate cyclase-C receptor activation: unexpected biology.
Stuart M Brierley. Curr Opin Pharmacol 2012
42
17

The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
Chantell Wilson, Jieru E Lin, Peng Li, Adam E Snook, Jianping Gong, Takahiro Sato, Chengbao Liu, Melanie A Girondo, Hallgeir Rui, Terry Hyslop,[...]. Cancer Epidemiol Biomarkers Prev 2014
34
17



The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel disease.
Øystein Brenna, Torunn Bruland, Marianne W Furnes, Atle van Beelen Granlund, Ignat Drozdov, Johanna Emgård, Gunnar Brønstad, Mark Kidd, Arne K Sandvik, Björn I Gustafsson. Scand J Gastroenterol 2015
34
17


Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
A P S Hungin, L Chang, G R Locke, E H Dennis, V Barghout. Aliment Pharmacol Ther 2005
312
11

Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives.
Manassés Claudino Fonteles, Nilberto Robson Falcão do Nascimento. Can J Physiol Pharmacol 2011
7
28

Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Viola Andresen, Michael Camilleri, Irene A Busciglio, April Grudell, Duane Burton, Sanna McKinzie, Amy Foxx-Orenstein, Caroline B Kurtz, Vineeta Sharma, Jeffrey M Johnston,[...]. Gastroenterology 2007
175
11

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract.
Alexander P Bryant, Robert W Busby, Wilmin P Bartolini, Etchell A Cordero, Gerhard Hannig, Marco M Kessler, Christine M Pierce, Robert M Solinga, Jenny V Tobin, Shalina Mahajan-Miklos,[...]. Life Sci 2010
118
11

Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.
Jeffrey M Johnston, Caroline B Kurtz, James E Macdougall, Bernard J Lavins, Mark G Currie, Donald A Fitch, Chris O'Dea, Mollie Baird, Anthony J Lembo. Gastroenterology 2010
156
11



Bacterial enterotoxins are associated with resistance to colon cancer.
G M Pitari, L V Zingman, D M Hodgson, A E Alekseev, S Kazerounian, M Bienengraeber, G Hajnóczky, A Terzic, S A Waldman. Proc Natl Acad Sci U S A 2003
115
11

Precursor structure, expression, and tissue distribution of human guanylin.
F J de Sauvage, S Keshav, W J Kuang, N Gillett, W Henzel, D V Goeddel. Proc Natl Acad Sci U S A 1992
140
11

Opossum colonic mucosa contains uroguanylin and guanylin peptides.
F K Hamra, W J Krause, S L Eber, R H Freeman, C E Smith, M G Currie, L R Forte. Am J Physiol 1996
41
11

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
Michael A Valentino, Jieru E Lin, Adam E Snook, Peng Li, Gilbert W Kim, Glen Marszalowicz, Michael S Magee, Terry Hyslop, Stephanie Schulz, Scott A Waldman. J Clin Invest 2011
98
11

Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin.
M Nakazato, H Yamaguchi, Y Date, M Miyazato, K Kangawa, M F Goy, N Chino, S Matsukura. Endocrinology 1998
51
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.